Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/52916
Campo DC Valoridioma
dc.contributor.authorRodríguez-Pérez, José C.en_US
dc.contributor.authorPlaza, Celiaen_US
dc.contributor.authorReyes, Ricardoen_US
dc.contributor.authorPulido-Duque, Juan M.en_US
dc.contributor.authorPalop, Leocadiaen_US
dc.contributor.authorFerral, Hectoren_US
dc.contributor.authorMaynar Moliner, Manuelen_US
dc.contributor.authorCastaneda-Zuniga, Wilfrido R.en_US
dc.contributor.otherRodriguez-Perez, J.C.-
dc.date.accessioned2019-02-04T14:19:56Z-
dc.date.available2019-02-04T14:19:56Z-
dc.date.issued1994en_US
dc.identifier.issn1051-0443en_US
dc.identifier.urihttp://hdl.handle.net/10553/52916-
dc.description.abstractPurpose The clinical results of percutaneous transluminal angioplasty (PTA) were evaluated in patients with renovascular hypertension, and the effect of PTA on blood pressure and renal function was determined. Patients and Methods Between February 1982 and December 1990, 93 hypertensive patients underwent 123 renal artery PTA procedures. Mean patient age was 43.4 years (range, 12–78 years). Average baseline blood pressure was 162/111 mm Hg (range, 140–230/95–150 mm Hg). The cause of renovascular hypertension, as determined with angi-ography, was atherosclerosis in 37 patients, fibromuscular dysplasia in 27, and mixed disease in one; 28 patients had renal transplant arterial stenosis. Results In patients with atherosclerotic renal vascular disease or fibromuscular renal artery stenosis, systolic and diastolic blood pressure decreased significantly (P < .001) at 96 months after PTA. In patients with renal transplant arterial stenosis, blood pressure also decreased significantly (P < .001) at 12 months after PTA. Technical success was achieved in 78% of patients with atherosclerosis, 92% of patients with fibromuscular dysplasia, and 76% of patients with renal transplants. Complications were seen in 4.8% and were related to renal failure and vessel dissection. Conclusion PTA is the therapy of choice in patients with renovascular hypertension due to fibromuscular dysplasia. Patients with atherosclerotic renal artery stenosis or stenosis of a renal artery in a transplanted kidney should be selected according to the anatomy of the lesion and clinical patient characteristics.en_US
dc.languageengen_US
dc.relation.ispartofJournal of Vascular and Interventional Radiologyen_US
dc.sourceJournal of Vascular and Interventional Radiology [ISSN 1051-0443], v. 5 (1), p. 101-109, (Enero 1994)en_US
dc.subject32 Ciencias médicasen_US
dc.subject321317 Cirugía vascularen_US
dc.subject320506 Nefrologíaen_US
dc.subject320111 Radiologíaen_US
dc.subject.otherHypertensionen_US
dc.subject.otherRenovascularen_US
dc.subject.otherRenal arteriesen_US
dc.subject.otherFibrodysplasiaen_US
dc.subject.otherTransluminal angioplastyen_US
dc.titleTreatment of Renovascular Hypertension with Percutaneous Transluminal Angioplasty: Experience in Spainen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/S1051-0443(94)71462-7en_US
dc.identifier.scopus0028249491-
dc.identifier.isiA1994NC90900006-
dcterms.isPartOfJournal Of Vascular And Interventional Radiology-
dcterms.sourceJournal Of Vascular And Interventional Radiology[ISSN 1051-0443],v. 5 (1), p. 101-109-
dc.contributor.authorscopusid7005446255-
dc.contributor.authorscopusid7005227541-
dc.contributor.authorscopusid57196596240-
dc.contributor.authorscopusid35583852200-
dc.contributor.authorscopusid7004690031-
dc.contributor.authorscopusid7003584240-
dc.contributor.authorscopusid7005962555-
dc.contributor.authorscopusid7101832612-
dc.description.lastpage109en_US
dc.identifier.issue1-
dc.description.firstpage101en_US
dc.relation.volume5en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:A1994NC90900006-
dc.contributor.daisngid245684-
dc.contributor.daisngid315895-
dc.contributor.daisngid7700931-
dc.contributor.daisngid1645196-
dc.contributor.daisngid751953-
dc.contributor.daisngid349282-
dc.contributor.daisngid23221678-
dc.contributor.daisngid70178-
dc.identifier.investigatorRIDC-1247-2010-
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.date.coverdateEnero 1994en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Patología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0003-0023-1063-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Pérez,José Carlos-
crisitem.author.fullNameMaynar Moliner,Manuel-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

28
actualizado el 24-mar-2024

Citas de WEB OF SCIENCETM
Citations

21
actualizado el 25-feb-2024

Visitas

54
actualizado el 18-feb-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.